Clinical Trial Update: Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE) [Phase 3]

View source ↗

Summary

Phase 3 trial ASPIRE is evaluating adaptive SBRT for localized prostate cancer versus image-guided radiotherapy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Localized Prostate Cancer, Stereotactic Body Radiotherapy | Phase 3 | Status: RECRUITING